Anthera Pharmaceuticals Inc Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013
REVENUES:
License revenue
Collaborative revenue
Total revenues
OPERATING EXPENSES:
Research and development
General and administrative
Research award
Total operating expenses
LOSS FROM OPERATIONS
Other income (expense), net
OTHER INCOME (EXPENSE):
Other income (expense)
Interest expense
Fair value of warrant liability in excess of proceeds from financing
Change in fair value of warrant liability
Total other income (expense)

NET LOSS
Unrealized gain on short-term investments, net
Comprehensive loss
Deemed dividends attributable to preferred stock
Net loss applicable to common stockholders
Net loss per share applicable to common stockholders-basic and diluted
Weighted-average number of shares used in per share calculation-basic and diluted

Comments